Relay Therapeutics, Inc. - Common Stock (NQ:RLAY)

Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

December 11, 2024

Relay Therapeutics shares are trading lower by 17.8% during Wednesday's session. The company priced its $200 million offering.

Why Relay Therapeutics (RLAY) Stock Is Down 17% Today ↗

September 11, 2024

Via Benzinga

Expert Ratings For Relay Therapeutics ↗

August 07, 2024

Via Benzinga

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium

December 09, 2024

Company to host conference call on Wednesday, December 11, 2024 at 7am ET

Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

December 03, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences

November 07, 2024

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

November 06, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024

October 30, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual...

AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week ↗

September 15, 2024

Investors weren't happy with the company's latest effort at capital-raising.

Why Relay Therapeutics Plummeted by Nearly 14% Today ↗

September 11, 2024

Via The Motley Fool

This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday ↗

September 11, 2024

Via Benzinga

GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 11, 2024

Via Benzinga

Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

September 11, 2024

Via Benzinga

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

September 10, 2024

Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market ↗

September 10, 2024

Relay Therapeutics shares interim data for RLY-2608 from the ReDiscover study, showing a 57% clinical benefit rate. Oppenheimer downgrades Relay Therapeutics from Outperform to Perform, citing concerns...

Via Benzinga

AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th ↗

September 10, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 and should result in as many as 50 novel therapies being brought to market by then and generate annual...

This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

September 10, 2024

Via Benzinga

Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone ↗

September 10, 2024

Via Benzinga

Topics Stocks

Relay Therapeutics Announces Proposed Public Offering of Common Stock

September 09, 2024

Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients ↗

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher ↗

September 09, 2024

Via Benzinga

Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July ↗

September 09, 2024

Via Benzinga

September 09, 2024

Monday, Relay Therapeutics Inc. (NASDAQ:RLAY) shared interim data for RLY-2608 from ReDiscover study, an ongoing first-in-human study, to evaluate the safety, tolerability, pharmacokinetics,...

Via Benzinga

Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday ↗

September 09, 2024

Via Benzinga

US Stocks Higher; Dow Surges Over 200 Points ↗

September 09, 2024

Via Benzinga

Topics Stocks

Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

September 09, 2024

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024

September 06, 2024

Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! ↗

September 05, 2024

The August ISM manufacturing index reported on Tuesday that figures came in below consensus expectation. That raised fears about the strength of the economy, driving down our Our AI-Focused Drug...

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030.

Topics Economy

Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week ↗

August 27, 2024